SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
tong
Lv1
10 积分
2023-12-20 加入
最近求助
最近应助
互助留言
Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune Microenvironment
12天前
已完结
PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways
12天前
已完结
Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab
12天前
已完结
Design, Synthesis, and Antitumor Activity Evaluation of 2-Arylmethoxy-4-(2,2′-dihalogen-substituted biphenyl-3-ylmethoxy) Benzylamine Derivatives as Potent PD-1/PD-L1 Inhibitors
12天前
已完结
Incorporating Selenium into Heterocycles and Natural Products─From Chemical Properties to Pharmacological Activities
13天前
已完结
Immune checkpoint receptors in autoimmunity
1个月前
已完结
Design, synthesis, and structure-activity relationship of programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing a benzo[d]isothiazole scaffold
2个月前
已完结
Blocking of the PD‐1/PD‐L1 Interaction by a D‐Peptide Antagonist for Cancer Immunotherapy
4个月前
已完结
Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1
4个月前
已完结
1049P Phase Ib/II trial of envafolimab, a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, plus lenvatinib in patients with selected advanced solid tumors
4个月前
已完结
没有进行任何应助
感谢,速度真快,帮大忙了,么么哒,点赞,点赞
12天前
感谢,点赞,速度真快,帮大忙了,么么哒
13天前
感谢,点赞,速度真快,帮大忙了,么么哒
1个月前
么么哒,帮大忙了,速度真快,感谢,点赞
4个月前
感谢,点赞,速度真快,速度真快,帮大忙了,么么哒
4个月前
感谢,点赞,速度真快,帮大忙了,么么哒
4个月前
感谢,点赞,速度真快,帮大忙了,么么哒
4个月前
感谢,点赞,速度真快,帮大忙了,么么哒
5个月前
感谢,点赞,速度真快,帮大忙了,么么哒
5个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论